Home / Letter From The Editor / Sept. 12, 2020

Sept. 12, 2020

Sep 12, 2020
 

When we see children who are diagnosed with type 1 diabetes to start therapy, we often are hesitant to go full bore because of the chance for a honeymoon period where their pancreas begins to produce insulin again. Although this honeymoon period is often short-lived, the risk of hypoglycemia is very high.

In the past we did not treat our older patients with type 1 the same way, as the consensus was they would likely not have the same hypoglycemic risk as children. Now, in a new series of articles that our intern Joel John, PharmD candidate FAMU College of Pharmacy, has researched, we find that this is not likely true.

 

Check out his article and why you need to pay attention to possible remissions for all your patients.

 

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief